Search results
File name Access Size Downloaded Type License Ivabradine in the Management of COVID-19-related Cardiovascular Complications.pdf available 1.9 MB 1 Publisher's version 
article
File name Access Size Downloaded Type License Lactacystin-induced kidney fibrosis- Protection by melatonin and captopril.pdf available 4.2 MB 2 Publisher's version article
Title Chronotherapy of cardiovascular pathologies: a hopeful strategy Author Šimko Fedor SAVBIOMED - Biomedicínske centrum SAV Co-authors Baka T. Action VEGA 1/0035/19. PROTEKCIA KARDIOVASKULÁRNEHO SYSTÉMU PRI EXPERIMENTÁLNEJ HYPERTENZII A ZLYHANÍ SRDCA DUÁLNOU INHIBÍCIOU NEPRILYZÍNU A AT1 RECEPTOROV PRE ANGIOTENZÍN II: POROVNANIE S ACE-INHIBÍCIOU A MELATONÍNOM VEGA 2/0112/19. Experimentálny infarkt myokardu: príspevok hypertenzie a obezity, účinok inhibítora toll-like receptorov Source document Therapeutic Advances in Chronic Disease. Vol. 13, apr. (2022), p. 1-3 Category ADCA - Scientific papers in foreign journals registered in Current Contents Connect with IF (impacted) Category of document (from 2022) V3 - Vedecký výstup publikačnej činnosti z časopisu Type of document článok Year 2022 DOI 10.1177/20406223221092372 URL URL link File name Access Size Downloaded Type License Chronotherapy of cardiovascular.pdf available 474.8 KB 1 Publisher's version article
Title Sacubitril/Valsartan and Ivabradine Attenuate Left Ventricular Remodelling and Dysfunction in Spontaneously Hypertensive Rats: Different Interactions with the Renin-Angiotensin-Aldosterone System Author Šimko Fedor SAVBIOMED - Biomedicínske centrum SAV Co-authors Baka T. Stanko Peter Repova Bednarova Kristina Krajčirovičová Kristína Aziriová S. Domenig O. Zorad Štefan SAVBIOMED - Biomedicínske centrum SAV Adamcová Michaela Paulis Ľudovít 1981- SAVNOPAT - Ústav normálnej a patologickej fyziológie SAV Action VEGA 1/0035/19. PROTEKCIA KARDIOVASKULÁRNEHO SYSTÉMU PRI EXPERIMENTÁLNEJ HYPERTENZII A ZLYHANÍ SRDCA DUÁLNOU INHIBÍCIOU NEPRILYZÍNU A AT1 RECEPTOROV PRE ANGIOTENZÍN II: POROVNANIE S ACE-INHIBÍCIOU A MELATONÍNOM APVV-20-0421. Kardiometabolické účinky stimulácie Mas receptorov modulovaním renín-angiotenzínového systému - klúčová úloha angiotenzín-konvertujúceho enzýmu 2 : 1.7.2021-30.6.2025 Source document Biomedicines. Vol. 10, no. 8 (2022), art. no. 1844 Category ADCA - Scientific papers in foreign journals registered in Current Contents Connect with IF (impacted) Category of document (from 2022) V3 - Vedecký výstup publikačnej činnosti z časopisu Type of document článok Year 2022 DOI 10.3390/biomedicines10081844 article
Title Cardiovascular therapeutics: A new potential for anxiety treatment? Author Repova Bednarova Kristina Co-authors Aziriová S. Krajčirovičová Kristína Šimko Fedor SAVBIOMED - Biomedicínske centrum SAV Action VEGA 1/0035/19. PROTEKCIA KARDIOVASKULÁRNEHO SYSTÉMU PRI EXPERIMENTÁLNEJ HYPERTENZII A ZLYHANÍ SRDCA DUÁLNOU INHIBÍCIOU NEPRILYZÍNU A AT1 RECEPTOROV PRE ANGIOTENZÍN II: POROVNANIE S ACE-INHIBÍCIOU A MELATONÍNOM VEGA 2/0112/19. Experimentálny infarkt myokardu: príspevok hypertenzie a obezity, účinok inhibítora toll-like receptorov Source document Medicinal Research Reviews. Vol. 42, no. 3 (2022), p. 1202-1245 Category ADCA - Scientific papers in foreign journals registered in Current Contents Connect with IF (impacted) Category of document (from 2022) V3 - Vedecký výstup publikačnej činnosti z časopisu Type of document článok Year 2022 DOI 10.1002/med.21875 File name Access Size Downloaded Type License Cardiovascular therapeutics A new potential for anxiety treatment.pdf available 2.5 MB 1 Publisher's version article
Title Commentary: Effect of Angiotensin-Converting-Enzyme Inhibitor and Angiotensin II Receptor Antagonist Treatment on ACE2 Expression and SARS-CoV-2 Replication in Primary Airway Epithelial Cells Author Šimko Fedor SAVBIOMED - Biomedicínske centrum SAV Co-authors Baka T. Action VEGA 1/0035/19. PROTEKCIA KARDIOVASKULÁRNEHO SYSTÉMU PRI EXPERIMENTÁLNEJ HYPERTENZII A ZLYHANÍ SRDCA DUÁLNOU INHIBÍCIOU NEPRILYZÍNU A AT1 RECEPTOROV PRE ANGIOTENZÍN II: POROVNANIE S ACE-INHIBÍCIOU A MELATONÍNOM VEGA 2/0112/19. Experimentálny infarkt myokardu: príspevok hypertenzie a obezity, účinok inhibítora toll-like receptorov Source document Frontiers in Pharmacology. Vol. 13, jan (2022), art. no. 842512 Category ADCA - Scientific papers in foreign journals registered in Current Contents Connect with IF (impacted) Category of document (from 2022) V3 - Vedecký výstup publikačnej činnosti z časopisu Type of document článok Year 2022 DOI 10.3389/fphar.2022.842512 File name Access Size Downloaded Type License Commentary Effect of of Angiotensin-Converting-Enzyme Inhibitor.pdf available 937.1 KB 2 Publisher's version article
Title Dual inhibition of neprilysin and angiotensin II type 1 receptor in light of clinical studies Par.title Duálna inhibícia neprilyzínu a receptora typu 1 pre angiotenzín II vo svetle klinických štúdií Author Baka T. Co-authors Stanko P. Hrenák Jaroslav Dukát A. Šimko Fedor SAVBIOMED - Biomedicínske centrum SAV Action VEGA 1/0035/19. PROTEKCIA KARDIOVASKULÁRNEHO SYSTÉMU PRI EXPERIMENTÁLNEJ HYPERTENZII A ZLYHANÍ SRDCA DUÁLNOU INHIBÍCIOU NEPRILYZÍNU A AT1 RECEPTOROV PRE ANGIOTENZÍN II: POROVNANIE S ACE-INHIBÍCIOU A MELATONÍNOM Source document Cardiology Letters. Vol. 30 , no. 1 (2021), p. 23-30 Category ADNB - Scientific papers in domestic non-impacted journals registered in Web of Sciences or Scopus Category of document (from 2022) V3 - Vedecký výstup publikačnej činnosti z časopisu Type of document článok Year 2021 DOI 10.4149/Cardiol_2021_1_5 URL URL link File name Access Size Downloaded Type License Dual inhibition of neprilysin and angiotensin II type 1 receptor.pdf available 147.9 KB 1 Publisher's version article
File name Access Size Downloaded Type License Renin Angiotensin Aldosterone System.pdf available 415 KB 3 Publisher's version article
Title Monitoring Non-dipping Heart Rate by Consumer-Grade Wrist-Worn Devices: An Avenue for Cardiovascular Risk Assessment in Hypertension Author Baka T. Co-authors Šimko Fedor SAVBIOMED - Biomedicínske centrum SAV Action VEGA 1/0035/19. PROTEKCIA KARDIOVASKULÁRNEHO SYSTÉMU PRI EXPERIMENTÁLNEJ HYPERTENZII A ZLYHANÍ SRDCA DUÁLNOU INHIBÍCIOU NEPRILYZÍNU A AT1 RECEPTOROV PRE ANGIOTENZÍN II: POROVNANIE S ACE-INHIBÍCIOU A MELATONÍNOM VEGA 2/0112/19. Experimentálny infarkt myokardu: príspevok hypertenzie a obezity, účinok inhibítora toll-like receptorov Source document Frontiers in Cardiovascular Medicine. Vol. 8, Jul (2021), art. no. 711417 Category ADCA - Scientific papers in foreign journals registered in Current Contents Connect with IF (impacted) Category of document (from 2022) V3 - Vedecký výstup publikačnej činnosti z časopisu Type of document článok Year 2022 DOI 10.3389/fcvm.2021.711417 URL URL link File name Access Size Downloaded Type License Monitoring Non-dipping Heart Rate by Consumer-Grade Wrist-Worn Devices An Avenue for Cardiovascular Risk Assessment in Hypertension.pdf available 638.8 KB 2 Publisher's version 
CC BY 4.0article
Title Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: potential allies in the COVID-19 pandemic instead of a threat? Author Šimko Fedor SAVBIOMED - Biomedicínske centrum SAV Co-authors Baka T. Action VEGA 1/0035/19. PROTEKCIA KARDIOVASKULÁRNEHO SYSTÉMU PRI EXPERIMENTÁLNEJ HYPERTENZII A ZLYHANÍ SRDCA DUÁLNOU INHIBÍCIOU NEPRILYZÍNU A AT1 RECEPTOROV PRE ANGIOTENZÍN II: POROVNANIE S ACE-INHIBÍCIOU A MELATONÍNOM VEGA 2/0112/19. Experimentálny infarkt myokardu: príspevok hypertenzie a obezity, účinok inhibítora toll-like receptorov APVV PP-COVID-20-0043. Nové perspektívy v liečbe kardiovaskulárnych komplikácií spojených s COVID-19 : Centrum experimentálnej medicíny SAV Source document Clinical Science. Vol. 135, no. 8 (2021), p. 1009–1014 Category ADCA - Scientific papers in foreign journals registered in Current Contents Connect with IF (impacted) Category of document (from 2022) V3 - Vedecký výstup publikačnej činnosti z časopisu Type of document článok Year 2021 DOI 10.1042/CS20210182 URL URL link File name Access Size Downloaded Type License Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers.pdf available 522.7 KB 2 Publisher's version article